Abstract
Inflammatory bowel disease (IBD) constitutes a group of chronic idiopathic inflammatory bowel conditions commonly subdivided into Crohn’s disease (CD), involving commonly the small bowel and or colon, and ulcerative colitis (UC), a condition confined to parts of or the entire large bowel (colon). About 5 to 10 per 100 000 inhabitants in Western countries are affected, with a peak incidence of onset of disease in their twenties causing a considerable burden, with usually need for chronic medications and in about 30–50% of patients need for surgery.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fiocchi C (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182–205
Wilckens T, De Rijk R (1997) Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol Today 18: 418–423
Bratts R, Linden M (1996) Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment Pharmacol Ther 10: 81–90
Jewell D, Rutgeerts P (eds) (1993) Reviewing steroids in the treatment of IBD. Res Clin Forum 15
Cortot A, Colombel JF, Rutgeerts P, Lauritsen K, Malchow H, Hamling J, Winter T, Pallant D, Petterson E (1999) Budesonide controlled ileal release capsules in prednisone dependent patient’s with Crohn’s disease. Gastroenterology 116:G3014
Hanauer S, Baert F (1995) The management of ulcerative colitis. Annu Rev Med 46: 497–505
Lichtiger S, Present D, Kornbluth A (1994) Cyclosporin in severe ulcerative colitis refractroy to steroid therapy. N Engl J Med 330: 1841–1850
Baert F, Hanauer S (1994) Cyclosporin in severe steroid resistant ulcerative colitis: long term results of therapy. Gastroenterology 106:A648
Summers RW, Switz DM, Sessions JT (1979) The national cooperative Crohn’s idsease study: resuls of drug treatment. Gastroenterology 77: 847–869
Malchow Ewe K, Brandes JW (1984) European cooperative Crohn’s disease study (ECCDS) results of drug treatment. Gastroenterology 86: 249–266
Prantera C, Zannoni F, Scribano ML, Berto E, Andreoli A, Kohn A, Luzi C (1996) An antibiotic regimen for the treatment of active Crohn’s disease: a randomised controlled clinical trial of metronidazol and ciprofloxacin. Amer J Gastroenterol 91: 328–332
Munckholm P, Langholz E, Davidsen M, Binder V (1994) Frequency of glucocorticoid resistance and dependency in Crohn’s disease. Gut 35: 360–362
Ewe K, Press AG, Singe CC, Stufler M, Ueberschaer B, Hommel G, Meyer zum Buschenfelde KH (1993) Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn’s disease. Gastroenterology 105: 367–372
Greenberg GR, Feagan BG, Martin F, Sutherlanbd LR, Thomson ABR, Williams CN, Nilsson LG, Persson T (1994) Oral budesoinde for active Crohn’s disease. N Engl J Med 331: 836–841
Rutgeerts P, Löfberg R, Malchow H, Lmaers C, Olaison G, Jewell D, Danielsson A, Goebell H, Thomson OO, Lorenz Meyer H et al (1994) A comparison of budesonide with prednisolone for active Crohn’s disease. N Engl J Med 331: 842–845
Campieri M, Ferguson A, Doe W, Persson T, L-GNilsson (1997) Oral budesonide is as effective as oral prednisolone in active Crohn’s disease. Gut 41: 209–214
Sandborn WJ, Van Os EC, Zins BJ (1995) An intravenous loading dose of azathioprine decreases time to response in patients with Crohn’s disease. Gastroenterology 109: 1808–1817
Wilschanski M, Sherman P, Pencharz P, Davis L, Corey M, Griffiths A (1996) Supplementary enteral nutrition maintains remission in paediatric Crohn’s disease. Gut 38: 543–548
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Basel AG
About this chapter
Cite this chapter
Baert, F.J., Rutgeerts, P.R. (2001). Glucocorticoids in the control of inflammatory bowel disease. In: Goulding, N.J., Flower, R.J. (eds) Glucocorticoids. Milestones in Drug Therapy MDT. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8348-1_12
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8348-1_12
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9528-6
Online ISBN: 978-3-0348-8348-1
eBook Packages: Springer Book Archive